Filtered By:
Source: Circulation Journal
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 194 results found since Jan 2013.
What Is the Best Anticoagulant Therapy in Acute-Phase Ischemic Stroke With Nonvalvular Atrial Fibrillation?
Circ J. 2021 Dec 25. doi: 10.1253/circj.CJ-21-1002. Online ahead of print.NO ABSTRACTPMID:34955481 | DOI:10.1253/circj.CJ-21-1002
Source: Circulation Journal - December 27, 2021 Category: Cardiology Authors: Shigeru Fujimoto Source Type: research
New-Onset Atrial Fibrillation in Patients With Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease - Insights From the CLAVIS-COVID Registry
CONCLUSIONS: Patients with NOAF had significantly worse outcomes as compared to patients with pre-existing AF and SR. The incidence of NOAF would be a useful predictor of clinical outcomes during hospitalization.PMID:35082216 | DOI:10.1253/circj.CJ-21-0911
Source: Circulation Journal - January 27, 2022 Category: Cardiology Authors: Takahide Sano Shingo Matsumoto Takanori Ikeda Shunsuke Kuroda Takeshi Kitai Taishi Yonetsu Shun Kohsaka Sho Torii Koichi Node Yuya Matsue Source Type: research
Premature Atrial Contractions and Their Determinants in a General Population of Japanese Men
CONCLUSIONS: PAC frequency was independently associated with age, height, smoking, alcohol consumption, heart rate, physical activity, and triglycerides.PMID:35185078 | DOI:10.1253/circj.CJ-21-0872
Source: Circulation Journal - February 21, 2022 Category: Cardiology Authors: Sabrina Ahmed Takashi Hisamatsu Aya Kadota Akira Fujiyoshi Hiroyoshi Segawa Sayuki Torii Naoyuki Takashima Keiko Kondo Yoshihisa Nakagawa Hirotsugu Ueshima Katsuyuki Miura SESSA Research Group Source Type: research
Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve
CONCLUSIONS: Among AF patients with an aortic BPV, no significant difference was observed in the composite outcome of adverse clinical events between patients treated with warfarin and those treated with DOACs, suggesting that DOACs can be used as alternatives to warfarin in these patients.PMID:35811134 | DOI:10.1253/circj.CJ-22-0226
Source: Circulation Journal - July 10, 2022 Category: Cardiology Authors: Makoto Miyake Misa Takegami Yuki Obayashi Masashi Amano Takeshi Kitai Tomoyuki Fujita Tadaaki Koyama Hidekazu Tanaka Kenji Ando Tatsuhiko Komiya Masaki Izumo Hiroya Kawai Kiyoyuki Eishi Kiyoshi Yoshida Takeshi Kimura Ryuzo Nawada Tomohiro Sakamoto Yoshisa Source Type: research
